Prelude Capital Management, LLC X4 Pharmaceuticals, Inc Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.41 - $7.4 $10,387 - $14,208	-1,920 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$6.09 - $9.15 $11,083 - $16,653	1,820 Added 1820.0%	1,920 $13,000
Q2 2020 Aug 14, 2020	BUY	$7.98 - $10.44 $798 - $1,044	100 New	100 $1,000
Q1 2020 May 15, 2020	SELL	$6.03 - $11.01 $1,206 - $2,202	-200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.93 - $14.33 $1,986 - $2,866	200 New	200 $2,000

106

103M

206K

291K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $37.1M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.